|
1. Ahn Y.S., Zerban H., Grobholz R.,and Bannasch P.(1992).Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney. Carcinogenesis 13:2329-2334. 2. Bannasch P.(1986). Preneoplastic lesions as end points in carcinogenicity testing I. Hepatic preneoplasia. Carcinogenesis 7:689-695. 3. Bannasch P., D'Introno A., Leonetti P., Metzger C., Klimek F.,and Mayer D. (1998). Early aberrations of energy metabolism in carcinogenesis. In :Bannasch P, Kanduc D, Papa S and Tager JM(eds)Cell growth and Oncogenesis, pp.191-212. Birkhaauser Verlag Basel, Switzerland. 4. Barry M.A., Behnke C.A.,and Eastman A. (1990).Activation of programmed cell death(apoptosis)by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40:2353-2362. 5. Beacousfeild P., Rainsbury R.,and Kalton G. (1965).Glucose-6-phosphate dehydrogense defiency and the incidence of cancer. Oncology 19:11 6. Berger N.A., Catino D.M.,and Vietti T.J. (1982).Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo . Cancer Res. 42:4382-4386. 7. Biaglow J.E., Jacobson B., Greenstock C.L.,and Raleigh J. (1977).Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models. Mol. Pharmacol. 13:269-282. 8. Biaglow J.E., Varnes M.E., Clark E.P.,and Epp E.R. (1983).The role of thiols in cellular response to radiation and drugs. Radit. Res. 95: 437-455. 9. Bokun R., Bakotin J.,and Milasinoric D. (1978).Semiquantitative cytochemical estimation of flucose-6-phosphate dehydrogenase activity in benign dissseases and carcinoma of the breast. Acta. Cytol. 31:249-252. 10. Bolander F.F. Jntroduction In:Molecular Endocrinology. Academic Press, san Diego, landon, pp1-23. 11. Boyland E.,and Chasseaud C.F. (1979).The role of glutathione and glutathione S-transferase in mercapturic acid biosynthesis. Adv. Cancer Res. 29:175-274. 12. Casalone R., Minelie E., Portensoso P.,and Giudici A. (1990). Clonal duplication of the Y chromosome and fra[X] [q28] in a case of epidermoid carcinoma of the esophagus. Cancer Genet. Cytogenet. 45:269-271. 13. Cassimos C., Sklavvunu-Tsurnktosglu S., Catriu D.,and Panajiotidu C. (1973).The incidence of G6PD disturbances in cancer patients. IRCS(73-3)27-2-2. 14. Chen J. (1992). The effects of Chinese tea on the occurrence of esophageal tumors induced by N-nitrosomethylbenzylamine in rats. Prev. Med. 21:385-391. 15. (CICAMS)Department of Cancer Epidemiology of Cancer Insititute of Chinese Academy of Medical Sciences. (1977). Preliminary investigation of the epidemiological factors of esophageal cancer in China. Res. Cancer Prev. Treatm. 2: 1-8. 16. Cocco P., Dessi S., Avataneo G., Picchiri G.,and Heinemann E. (1989). Glucose-6-phosphate dehydrogenase deficiency and cancer in a sardinian male population:A case-control study. Carcinogenesis 10:813-816. 17. Cooper G.M. (1993). Common solid tumors of adults. In: The cancer book: a guide to understanding the causes, prevention and treatment of cancer. pp. 174-193. 18. Couillard S., labrie C., belanger A., Candas B., Pouliot F.,and Labrie F. (1998). Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts. J. Natl. Cancer Inst. 90: 772-778. 19. De Flora A., Morelli A.,and Giuliano F. (1974). Human erythrocyte glucose-6-phosphate dehydrogenase. Content of bound coenzyme. Biochem. Biophys. Res. Commun. 59:406-413. 20. Dessi S., Batetta B., Cherchi R., Onnis R., Pisano M.,and Pani P. (1988). Hexomonophosphate shunt enzymes in lung tumors from normal and glucose-6-phosphaate dehydrogenase-deficient subjects. Oncol. 45:287-291. 21. Dutu R., Nedelea M., Veluda G.,and Burcuket V. (1980). Cytoenzymologic investigations on carcinomas of the cervix uteri. Acta. Cytol. 24:160-166. 22. Dworkin C.R., Gorman S.D., Pashko L.L., Cristofalo V.J.,and Schwartz A.G. (1986). Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo-and deoxyribo-uncleosides. Life Sci. 38: 1451-1457. 23. Eckdahl S., Shah G.M., Poirier G.G., Reid J.M., Ames M.M.,and kaufmann S.H. (1998). 6-Aminonicotinamde sensitizes human tumor cell lines to cisplatin. Clin. Cancer Res. 4:117-130. 24. Epel D. (1963). Effect of carbon monoxide on ATP level and rate of mitosis in the urchin egg. J.Cell Biol. 17: 315-319. 25. Labrie F.,Belanger A.,Van L.T., Labrie C., Simard J., Cusan L.N., Gomez J.L.,and Candas B. (1998). DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues:Its role during aging. Steroids 63: 322-328. 26. Forteleoni G., Argiolas L., Farris A., Ferraris A.M., Gaetani G.F.,and Meloni T.(1988). G6PD deficiency and breast cancer. Tumori. 74:665-667. 27. Franze A., Ferrante M.I., Fusco F., Santoro A., Sanzari E., Martini G.,and Ursini M.V. (1998). Molecular anatomy of the human glucose-6-phosphate dehydrogenase core promoter. FEBS Letters 437:313-318. 28. Gaetani G.F., Galiano S., Canepa L., Ferraris A.M.,and Kirkman H.N. (1989). Catalase and glutathione peroxidase. Blood 73:334-339. 29. Garcea R., Daino L., Pascale R., Frassetto S., Cozzolino P., Ruggin M.E.,and Feo F. (1987). Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. Toxicol. Pathol. 15:164-169. 30. Garcea R., Daino L., Frassetto S., Cozzolino P., Ruggiu M.E., Vannini M.G., Pascale R., Lenzerini L.,Simile M.M.,Pudda M.,and Feo F. (1988). Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis. Carcinogenesis 9:931-938. 31. Garcia-Jimenez C., Benito B., Jolin T.,and Santisteban P. (1994). Insulin regulation of malic enzyme gene expression in rat liver: evidence for nuclear proteins that bind to two putative insulin response elements. Mol. Endocrinol. 8: 1361-1369. 32. Gimenez A., Minguela A., Parrilla P., Bermejo J., Perez D., Molina J., Garcia A.M., Alvarez R.,and Haro L.M. (1998). Flow cytometric DNA analysis and p53 protein expression show a good correlation with histologic findings with Barrett's esophagus. Cancer 83(4):641-651. 33. Gordon G.B., Newitt J.A., Shantz L.M., Weng D.E.,and Talalay P. (1986). Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandroserone and related anticarcinogenic steroids. Cancer Res. 46: 3389-3395. 34. Gordon G.B., Shantz L.M.,and Talalay P. (1987). Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Adv. Enzyme Res. 26:355-382. 35. Griffiths O.W., Anderson M.E.,and Meister A. (1979). Inhibition of glutathione biosynthesis by prothionine sulfoximine(s-n-propyl homo cysteine sufloxime), a selective inhibitor of glutamylcysteine synthetase. J. Biol. Chem. 254:1206-1210. 36. Hamilton S.R., Gordon G.B., Floyd J.,and Golightly S. (1991). Evaluation of dietary dehydroepiandrosterone for chemoprotection against tumorigenesis in premalignant colonic epithelium of male F344 rat. Cancer Res. 51: 476-480. 37. Herter F.P.,Weissman S.G., Thompson H.G., Hyman G.,and Martin D.S. (1961). Clinical experience with 6-aminonicotinamide. Cancer Res. 21:31-37. 38. Hu C.P., Hsieh H.G., Chien K.Y., Wang P.Y., Wang C.I., Chen C.Y., Lo S.J., Wuu K.D.,and Chang C. (1984) Biologic properties of three newly established human esophageal carcinoma cell lines. J. Natl. Cancer Inst. 72: 577-583. 39. Hughes E.C. (1976). The effect of enzymes upon metabolism, storage, and release of carbohydrates in normal and abnormal endometria. Cancer 38:487-502. 40. Johnson W.J.,and McColl J.D.(1955). 6-Aminonicotinamide-1 potent nicotinamid antagonist. Science 122:834 41. Keniry M.A., Hollander C.,and Benz C.C. (1989). The effect of gossypoland 6-aminonicotinamide on tumor cell metabolism:a 31P-magenatic resonance spectroscopic study. Biochem. Biophys. Res. Commun. 164:947-953. 42. Kensler T.W.,and Trush M..A. (1984). Role of oxygen radicals in tumor promotion. Environ. Mutagenesis 6: 593-616. 43. Kirkman H.N.,and Gaetani G.F. (1986). Regulation of glucose-6-phosphate dehydrogenase in human erythrocytes. J. Biol. Chem. 261:4033-4038. 44. Kletzien R.F., Prostko C.R., Stumpo D.J., McClung J.K.,and Dreher .KL. (1985). Molecular cloning of DNA sequences complementary to rat liver glucoes-6-phosphate dehydrogenase mRNA: nutritional regulation of mRNA level. J. Biol. Chem. 260:5621-5624. 45. Kletzien R.F., Clarke S.D.,and Ulrich R.G. (1992) . Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol. Parmacol. 41: 393-398. 46. Kletzien R.F.,and Berdanier C.D. (1993). Glucose-6-phosphate dehydrogenase: diet and hormone influences on de novo enzyme synthesis. In: Nutrition and gene expression (Berdanier C.D., and Hargrove J.L. eds) CRC Press, Boca Raton. pp. 187-206 . 47. Kletizen R.F., Harris P.K.,and Foellmi L.A. (1994). Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients and oxidant stress. FASEB. 8:174 -181. 48. Koutcher J.A., Alfieri A.A., Stolfi R.L., Devitt M.L., Colofiore J.R.,and Martin D.S. (1993). Potentiation of a three drug chemotherapy regimen by radition. Cancer Res. 53:3518-3523. 49. Koutcher J.A., Alfieri A.A., Matei C., Meyer K.L., Street J.C.,and Martin D.S. (1996). Effect of 6-aminonicotinamide on the pentose phosphate pathway:31P NMR and tumor growth delay studies. Magn. Reson. Med. 36:887-892. 50. Koutcher J.A., Alfieri A.A., Thaler H., Matei C.,and Martin D.S. (1997). Radioation enhancement by biochemical modulation and s-fluorouracil. Int. J. Radiation Oncology Biol. Phys. 39(5):1145-1152. 51. Kuo W.Y., and Tang T.K. (1998a). Effect of G6PD overexpression in NIH3T3 cells treated with ter-butyl hydroperoxide or paraquat. Free Radic. Biol. Med.24(7-8):1130-1138. 52. Kuo W.Y., and Tang T.K. (1998b). Tumorigenic transformation of NIH3T3 cells by glucose-6-phosphate dehydrogenase (G6PD). Mol. Biol. Cell vol.19 supplement p490a (abstract). 53. Kuo W.Y. (1999博士論文). The role of glucose-6-phosphate dehydrogenase (G6PD) in antioxidation and tumorigenesis. 54. Labrie F., Belanger A., Luu-The V., Labrie C., Simard J.,Cusan L., Gomez J.L.,and Candas B. (1998). DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: it role during aging. Steroids 63: 322-328. 55. Li J.Y. (1981). Epidemiology of esophageal cancer in China. In Third Symposium on epidemiology and cancer regestries in the pacific Basin, Maui, Hawaii. pp113-120. 56. Li S., Yan X., Belanger A.,and Labrie F. (1994). Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7, 12-dimethylbenz(a)-anthracene(DMBA)in the rat. Breast Cancer Res. Treat 29:203-217. 57. Li J.Y. (1987). Epidemiology of esophageal cancer in China. In: Cancer of the Liver, Esophgus, and Nasopharynx (Wagner G and Zhang YH eds) pp. 85-96 Springer-Verlag Berlin Heidelberg. 58. Liu B. (1984). Investigation of the risk factors of esophageal cancer. China J. Oncol. 6: 295- 59. Lopes S.A., and Rene A. (1973). Effect of 17-ketosteroids on glucose-6-phosphate dehydrogenase(G6PD) activityand on G6PD isoenzymes. Proc. Soc. Expl. Biol. Med. 142: 258-261. 60. Louie P., Nakayama R.,and Holten D. (1990). Solution hybridization quantitation of G6PD mRNA in rat epididymal fat pads. Biochem. Biophys. Acta. 1087:25-30. 61. Lubet R.A., Gordon G.B., Prough R.A., Lei X.D., You M., Wang Y., Grubbs C.J., Steele V.E., Kolloff G.J., Thomas C.F.,and Moon R.D. (1998). Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone:dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. Cancer Res. 58:921-926. 62. Mahmood U., Street J.C., Martei C., Ballon D., Martin D.S.,and Koutcher J.A. (1996). In vivo detection by 31P NMR of pentose phospate pathway block secondary to biochemical modulation. NMR in Biomed. 9:114-120. 63. Marks P.A.,and Banks J. (1960). Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroid. Proc. Natl. Acad. Sci. USA 45: 447-452. 64. Meister A.,and Anderson M. (1983). Glutathione. Annu. Rev. Biochem. 52:711-760. 65. Mohsenin V.,and Latifpour J. (1990). Respiratory burst in alveolar macrophages of diabetic rats. J. Appl. Physiol. 68: 2384-2390. 66. Moore M.A., Thamavit W., Ichihara A., Sato K.,and Ito N. (1986). Influence of dehydroepiandrosterone, diaminopropane and butylated hydroxy-anisole treatment during the induction phase of rat liver nodular lesions in a short-term system. Carcinogercesis 7:1059-1063. 67. Moore M.A., Thamavit W., Tsuda H.,and Ito N. (1986). The influence of dehydroepiandrosterone, diaminopropane, phenobarbital, butylated hydroxyanisole and butylated hydroxy-toluene treatment on the development of preneoplastic and neoplastic lesions in the rat initiated with dihydroxy-di-n-propylnitrosamine. Cancer Lett. 30:153-160. 68. Morelli A., Benatti U., Guiliano F.,and De Flora A. (1976). Human erythrocyte glucose-6-phosphate dehydrogenase. Evidence for competitive bind of NADP and NADPH. Biochem. Biophys Res. Commun. 70: 600-606. 69. Naik S.N.,and Anderson D.E. (1971). The association between glucose-6-phosphate dehydrogenase deficiency and cancer in American negroes. Oncology 25:356-364. 70. Nasr L.B., Monet J.A., Lucas P., and Bader C.A. (1989). Vitamin D3 and glucose-6-phosphate dehydrogenase in rat duodenal epithelial cells. Am. J. Physiol. 193:G760-G765. 71. Nyce J.W., Magee P.N., Hard G.C., and Schwartz A.G. (1986). Inhibition of 1,2-dimethyl hydrazine-indnced colon tumorigenesis in Ba1b/c mice by dehydroepiandrosterone. Carcinogeresis 7:311-316. 72. Pashko L.L., Rovito R.J., Williams J.R., Sobel E.L., and Schwartz A.G. (1984). Dehydroepiandrosterone(DHEA) and 3b-methylandrost-5-en-17-one:inhibitors of 7, 12-dimethylbenz(a)anthracene(DMBA)-intitiated and 12-o-tetradecanoyl-phorbol-13-acetate(TPA)-promoted skin papilloma formation in mice. Carcinogenesis 5: 463-466. 73. Pashko L.L., Hard G.C., Rovito R.J., Williams J.R., Sobel E.L., and schwartz A.G. (1985). Inhibition of 7, 12-dimethylbenz(a)anthracene-induced skin papillomas and carcinomas by dehydroepiandrosterone and 3b-methylandrost-5-en-17-one in mice. Cancer Res. 45:164-166. 74. Persico M.G., Viglietto G., Martino G., Toniolo D., Paonessa G., mescatelli C., Dono R., Vulliamy T., luzzatto L., Durso M. (1986). Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones:Primary structure of the protein and unusual 5' non-coding region. Nucleic acids Res. 14:2511-2522. 75. Philippe M., Larondelle Y., Lemaigre F., Mariame B., Delhez H., Mason P., Luzzatte L., and Rousseau G.G. (1994). Promoter function of the human glucose-6-phosphate dehydrogenase gene depends on two GC boxes that are cell specifically controlled. Eur. J. Biochem. 226:377-384. 76. Prosto C.R., Fritz R.S., and Kletzien R.F. (1989). Nutritional regulation of hepatic glucose-6-phosphate dehydrogenase: transient activation of transcription. Biochem. J. 258:295-299. 77. Raineri R., and Levy H.R. (1970). On the specificity of steroid interaction with mammary gland glucose-6-phosphate dehydrogenase. Biochemistry 9:2233-2243. 78. Rao K.N., Shinozuka H., Kunz H.W., and Gill III, Th., J. (1984). Enhanced Susceptibility to chemical carcinogen in rats carrying MHC-linked genes influencing development(grc). Int. J. Cancer 34:113-120. 79. Rattazzi M.C. (1968). Glucose-6-phosphate dehydrogenase from human erythrocytes:molecular weight determination by gel filtration. Biochem. Biophys. Res. Commun. 31:16-24. 80. Realini C.A., and Althaus F.R. (1992). Histone shutting by poly(ADP-ribosylation)J. Biol. Chem. 267: 18858-18865. 81. Ritter E.J., Scott W.J., and Wilson J.G.: Inhibition of ATP synthesis associated with 6-aminonicotinamide (6AN). Teratology 12:233-238. 82. Roberts W., Kartha M., and Sagore A.L. (1979). Effect of urradiation on the hexose monophosphate shunt pathway of human lymphocytes. Radiat. Res. 79:601-610. 83. Sanz N., Diez-Fernandez C., Valverde A.M., Lorenzo M., Benito M., and Cascales M. (1997). Malic enzyme and glucose-6-phosphate dehydrogenase gene expression increases in rat liver cirrhogenesis. Brit. J. Cancer 75(4): 487-492. 84. Satoh M.S., Poirier G.G., and Lindahl T. (1993). NAD+ dependent repair of damaged DNA by human cell extracts. J. Biol. Chem. 268:5480-5487. 85. Schulz S., and Nyce J.W. (1991). Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro. Cancer Res. 51:6563-6567. 86. Schulz S., klann R.C., Schonfeld S., and Nyce J.W. (1992). Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone:Role of isoprenoid biosynthesis. Cancer Res. 52:1372-1376. 87. Schwartz A.G. (1979). Inhibition of spontaneous breast cancer formation in female C3H (Avy/a)mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 39:1129-1132. 88. Schwartz A.G., and Tannen R.H. (1981). Inhibition of 7, 12-dimethylbenz [ a ] anthracene and urethan-induced lung tumor formation in A/J mice by long-tern treatment with dehydroepiandrosterone. Carcinogenesis 2:1335-1337. 89. Schwartz A.G., Gordon H.C., Pashko L.L., Abou-Gharbia M., and Swern D. (1981). Dehydroepiandrosterone:an anti-obesity and anti-carcinogenic agent. Nutr. Cancer 3:46-53. 90. Schwartz A.G., and Pashlo L.L.(1986). Food restriction inhibits [3H]7, 12-dimethyl benz[a] anthracene binding to mouse skin DNA and tetradecanoylphorbol -13-acetate stimulation of epidermal [3H] thymidine incorporation. Anticancer Res 6:1279-1282. 91. Schwartz A.G., Whitcomb J.M., Nyce J.W., Lewbert M.L., and Pashko L.L. (1988). Dehydroepiandrosterone and structural analogs:a new class of cancer chemopreventic agents. Adv. Cancer Res. 51:391-424. 92. Schwartz A.G., Fairman D.K., Polansky M., Lewbert M.L., and Pasko L.L. (1989). Inhibition of 7, 12-dimethylbenz(a )anthracene-initiated and 12-o-tetradecanoyl-phorbol-13-autate-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Carcinogenesis 10:1809-1813. 93. Sheffield V.C., and Seegmiller R.E. (1980). Impaired energy metabolism as an initial step in the mechenism for 6-aminonicotinamide-induced limb malformation. J. Embryol. Exp. Morphol. 59:217-222. 94. Shibata M.A., Hasegawa R., Imaida K., Hagiwara A., Ogawa K., Hirose M., Ito N., and Shirai T. (1995). Chemoprevention by dehydroepiandrosterone and indomethacin in a rat multiorgan carcinogenesis model. Cancer Res. 55:4870-4874. 95. Shibata M.A., Shirai T., Asakawa E., Hirose M., and Fukushima S. (1993). Inhibition by dehydroepiandrosteroine of butylated hydroxyanisole(BHA)promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia. Int. J. Cancer 53:819-823. 96. Smith E.R., and Barker K.L. (1974). Effects of estradiol and NADP on the rate of synthesis of uterine glucose-6-phosphate dehydrogenase. J. Biol. Chem. 249:6541-6547. 97. Smith T.J., Liao A., Wang L.D., Yang G.Y., Starcic S., Philbert M.A., and Yang C.S. (1998). Characterization of xenobiotic- metabolizing enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis 19(4): 667-672. 98. Srivastava S.K.and Beutler E. (1970). Glutathione metabolism of the erythrocyte. The enzymic cleavage of glutathione-hemoglobin preparation by glutathione reductase. Biochem. J. 119:353-357. 99. Stahl F., Schnorr D., Pilz C.,and Dorner G. (1992). Dehydroepiandrosterone(DHEA)levels in patients with prostatic cancer, heart diseases and under surgery stress. Exp. Clin. Endocrinol. 99:68-70. 100. Stanton R.C., Seifter J.L., Boxer D.C., Zimmerman E., and Cantley L.C. (1991). Rapid release of bound glusose-6-phosphate dehydrogenase by growth factor. J. Biol. Chem. 266(19):12442-12448. 101. Stolfi R.L., Colifiore J.R., Nord L.D., Koutcher J.A., and Martin D.S. (1992). Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast turmors with a 5-FU containg drug regimen. Cancer Res. 52:4074-4081. 102. Street J.C., Mahmood U., Ballon D., Alfieri A.A., and Koutcher J.A. (1996). 13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro. J. Biol. Chem. 71:4113-4119. 103. Street J.C., Alfieri A.A., and Koutcher J.A. (1997) . Quantitation of metabolic and radiobiological effect of 6-aminonictinamide in RIF-1 tumor cells in vitro . Cancer Res. 57:3956-3962. 104. Stumpo D.J., and Kletzien R.F. (1984). Regulation of glucose-6-phosphate dehydrogenase mRNA by insulin and the glucocorticoids in primary clutures of rat heptocytes. Eur. J. Biochem. 144:497-502. 105. Stumpo D.J., and Kletzien R.F. (1985). The effect of ethanol,alone and in combination with the glucocorticoids and insulin, on glucose-6-phosphate dehydrogenase synthesis and mRNA in primary cultures of hepatocytes. Biochem. J. 226:123-130. 106. Sulis E.(1972).G-6-PD deficiency and cancer. Lancet 1:1185. 107. Sweet S., and Singh G. (1995). Accumulation of human promyelocytic leukemic (HL-60) cells at two energetic cell cycle checkpoints. Cancer Res. 55:5164-5167. 108. Thorton M., Moore M.A., and Ito N. (1989). Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinaar pancreatic preneoplastic lesions in the rat. Carcinogenesis 10:407-410. 109. Tomlinson J.E., Nakayama R.,and Holten D. (1988). Repression of pentose phosphate pathway dehydrogenase synthesis and mRNA by dietary fat in rats. J. Nutr. 118:408-415. 110. Tonilol D., Martini G., Migeon B.R.,and Dono R. (1988). Expression of the G6PD locus on the human X chromosome is associated with demethylation of three CpG islands within 100kb of DNA. EMBO J. 7:401-406. 111. Toniolo D., Filippi M., Dono R., Lettieri T.,and Martini G. (1991). The CpG island in the 5' region of the G6PD gene of man and mouse. Gene 102:197-203. 112. Ursini M.V., Parrella A., Rosa G.,and Martini G. (1970). Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem. J. 323: 801-806. 113. Ursini M.V., Scalera L.,and Martini G.(1990). High levels of transcription driven by a 400bp segment of the human G6PD promoter. Biochem. Biophys. Res. Commun. 170:1203-1209. 114. Varmus H.,and Weinberg R.A., (1993). The genetic elementsgoverning cancer:proto-oncogenes.In genes and the biology of cancer. pp.67-99 Scientific American Library. 115. Varnes M. (1988). Inhibition of prntose cycle of A549 cells by 6AN: Consequences for aerobic and hypoxic radiation response and for radiosensitizer action. NCI Monograph 6:199-203. 116. Wang, Z.Y., Wang L.D., Lee M.J., Ho C.T., Huang M.T., Conney A.H., and Yang C.S. (1995). Inhibition of N-nitrosomethylbenylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 16: 2143-2148. 117. Weber E., Moore M.A., and Bannasch P. (1988). Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induce hemangiosarcoma and adrenal lesion development in Sprague Dawley rats by dehyddroepiandrosterone. Carcinogenesis 9:1191-1195. 118. Westermwn M.P., Wald N., Diloy-Puray M. (1980). Irradiation shortens the survival time of red cells deficient in glucose-6-phosphate dehydrogenase. Radiat. Res. 81(3):473-477. 119. White E.L., Ross L.J., Schmid S.M., Kelloff G.J., Steele V.E., and Hall D.L. (1998). Screening of potential cancer preventing chemicals for induction of glutathione in rat liver cells. Oncology reports 5:507-512. 120. Wrigley N.G., Heather J.V., Bonsignore A.,and De Flora A. (1972). Human erythrocyte glucose-6-phosphate dehydrogenase:Electron microscope studies on structure and interconversion of tetramers, dimers and monomers. J. Mol. Biol. 68:483-499. 121. Yoshimoto K., Makamura T., and Ichiara A. (1983). Reciprocal effects of epidermal growth factor on key lipogenic enzymes in primary cultures of adult rat hepatocytes. Induction of glucose-6-phosphate dehydrogenase and suppression of malic enzyme and lipogenesis. J. Biol. Chem. 258:12355-12360. 122. Zampella E.J., Bradley E.L., and Pretlow T.G.(1982). Glucose-6-phosphate dehydrogenase:a possible clinical indicator for prostatic carcinoma. Cancer 49:384-387. 123. Zimmer H.G., Lankat-Buttgereit B., Kolbeck-Ruhmkorff C., Nagano T., and Zierhut W. (1992). Effects of norephrine on the oxidative pentose phosphate pathway in the rat heart. Circ. Res. 71:451-459. 124. Zumoff B., Levin J., Rosenfeld R.S., Markham M., Strain G.W.,and Fukushima D.K.(1981). Abnormal 24-hr mean plasma conceutration of dehydroepiandrosterone and dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res. 41:3360-3363.
|